Sarepta sinks as FDA changes investigational drug process
June 02, 2016 at 12:30 PM EDT
Shares of Sarepta Therapeutics slumped after the Food and Drug Administration finalized new procedures for expanded access for unapproved drugs.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.